Dermatological Disorders

Xeomin Approved for Improvement of Frown Lines

Merz Aesthetics announced that Xeomin (incobotulinumtoxinA) has been approved for the temporary improvement in the appearance of moderate to severe glabellar lines, or frown lines between the eyebrows, in adult patients.